Concomitant cardiac ATTR amyloidosis and hypertrophic obstructive cardiomyopathy treated with a cardiac myosin inhibitor

10 May 2026 (15:57 - 16:06)
Organised by: Logo
Congress Presentation Part of: Cardiac amyloidosis in practice Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by